Literature DB >> 10392751

MRI abnormalities in neurofibromatosis type 1 (NF1): a study of men and mice.

T Rosenbaum1, V Engelbrecht, W Krölls, F A van Dorsten, M Hoehn-Berlage, H G Lenard.   

Abstract

Hyperintense lesions on T2-weighted MR images of the brain, predominantly located in the basal ganglia, the brainstem and cerebellum, are a frequent finding in patients with neurofibromatosis type 1. Nature and significance of these lesions are still unknown so that the term 'unidentified bright objects' (UBOs) has been introduced to allow an unbiased description. We analyzed brain MRI scans of 31 children with definite diagnosis of neurofibromatosis type 1 according to the NIH criteria. High-intensity lesions on T2-weighted images were present in 86% of the patients. They did not correlate to other MRI findings such as optic pathway gliomas and were not indicative of intellectual impairment. Additionally, brain MR imaging of Nf1 knockout mice was performed to find out if similar abnormalities are present in this animal model. A total of 9 Nf1 knockout mice was examined on a dedicated animal MRI scanner at 4.7 Tesla but no evidence of high-signal intensity lesions on T2-weighted images was found. Therefore, the Nf1 mouse model seems to be unhelpful in providing further insights into the histological basis of hyperintense MRI abnormalities in NF1 patients.

Entities:  

Mesh:

Year:  1999        PMID: 10392751     DOI: 10.1016/s0387-7604(99)00024-8

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  11 in total

1.  Cerebellar atrophy in human and murine succinic semialdehyde dehydrogenase deficiency.

Authors:  Maria T Acosta; Jeeva Munasinghe; Phillip L Pearl; Maneesh Gupta; Andrey Finegersh; K Michael Gibson; William H Theodore
Journal:  J Child Neurol       Date:  2010-05-05       Impact factor: 1.987

2.  Spatial gene expression analysis of neuroanatomical differences in mouse models.

Authors:  Darren J Fernandes; Jacob Ellegood; Rand Askalan; Randy D Blakely; Emanuel Dicicco-Bloom; Sean E Egan; Lucy R Osborne; Craig M Powell; Armin Raznahan; Diane M Robins; Michael W Salter; Ameet S Sengar; Jeremy Veenstra-VanderWeele; R M Henkelman; Jason P Lerch
Journal:  Neuroimage       Date:  2017-09-04       Impact factor: 6.556

3.  Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.

Authors:  L I Petrella; Y Cai; J V Sereno; S I Gonçalves; A J Silva; M Castelo-Branco
Journal:  Genes Brain Behav       Date:  2016-07-05       Impact factor: 3.449

4.  Visual evoked potentials in children with neurofibromatosis type 1.

Authors:  Alessandro Iannaccone; Richard A McCluney; Vickie R Brewer; Peter H Spiegel; June S Taylor; Natalie C Kerr; Enikö K Pivnick
Journal:  Doc Ophthalmol       Date:  2002-07       Impact factor: 2.379

5.  Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.

Authors:  Zlatko Sabol; Biserka Resić; Romana Gjergja Juraski; Filip Sabol; Matilda Kovac Sizgorić; Kresimir Orsolić; David Ozretić; Dubravka Sepić-Grahovac
Journal:  Croat Med J       Date:  2011-08-15       Impact factor: 1.351

6.  A role for sustained MAPK activity in the mouse ventral telencephalon.

Authors:  Mary Jo Talley; Diana Nardini; Shenyue Qin; Carlos E Prada; Lisa A Ehrman; Ronald R Waclaw
Journal:  Dev Biol       Date:  2021-03-26       Impact factor: 3.148

7.  Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.

Authors:  Susan Byrne; Steve Connor; Karine Lascelles; Ata Siddiqui; Darren Hargrave; Rosalie E Ferner
Journal:  J Neurooncol       Date:  2017-06-07       Impact factor: 4.130

Review 8.  Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome.

Authors:  Carl E Stafstrom; Verena Staedtke; Anne M Comi
Journal:  Front Neurol       Date:  2017-03-17       Impact factor: 4.003

9.  Medullary unidentified bright objects in Neurofibromatosis type 1: a case series.

Authors:  Alessandra D'Amico; Federica Mazio; Lorenzo Ugga; Renato Cuocolo; Mario Cirillo; Claudia Santoro; Silverio Perrotta; Daniela Melis; Arturo Brunetti
Journal:  BMC Pediatr       Date:  2018-02-28       Impact factor: 2.125

10.  Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1.

Authors:  Jennifer L Griffith; Stephanie M Morris; Jasia Mahdi; Manu S Goyal; Tamara Hershey; David H Gutmann
Journal:  Neurol Clin Pract       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.